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Background: Mutations in calcium-responsive transactivator (CREST) encoding gene have been recently linked to
ALS. Similar to several proteins implicated in ALS, CREST contains a prion-like domain and was reported to be a
component of paraspeckles.
Results: We demonstrate that CREST is prone to aggregation and co-aggregates with FUS but not with other
two ALS-linked proteins, TDP-43 and TAF15, in cultured cells. Aggregation of CREST affects paraspeckle integrity,
probably by trapping other paraspeckle proteins within aggregates. Like several other ALS-associated proteins, CREST is
recruited to induced stress granules. Neither of the CREST mutations described in ALS alters its subcellular localization,
stress granule recruitment or detergent solubility; however Q388stop mutation results in elevated steady-state levels
and more frequent nuclear aggregation of the protein. Both wild-type protein and its mutants negatively affect neurite
network complexity of unstimulated cultured neurons when overexpressed, with Q388stop mutation being the most
deleterious. When overexpressed in the fly eye, wild-type CREST or its mutants lead to severe retinal degeneration
without obvious differences between the variants.
Conclusions: Our data indicate that CREST and certain other ALS-linked proteins share several features implicated in
ALS pathogenesis, namely the ability to aggregate, be recruited to stress granules and alter paraspeckle integrity. A
change in CREST levels in neurons which might occur under pathological conditions would have a profound negative
effect on neuronal homeostasis.
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(FUS), TAR DNA‐binding protein 43 (TDP‐43), Protein aggregation, Stress granule, Neurodegeneration, Paraspeckle,
Nuclear enriched abundant transcript 1 (NEAT1), Transgenic flyBackground
Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset
neurodegenerative condition characterized by aetiologically
diverse pathomechanisms, which ultimately results in loss
of upper and lower motor neurons, paralysis and death. In
a rapidly growing group of genes mutated in ALS the most
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and functional studies of ALS-associated proteins and their
disease-linked variants have significantly contributed to
our current understanding of the mechanisms of disease
development and progression. Characterization of patho-
logical signatures for each ALS-associated protein is cru-
cial in delineating common pathways in the disease
pathogenesis and eventually understanding how altered
metabolism of proteins with diverse functions results in
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trios Chesi and co-workers [4] have identified two mutations
in the SS18L1 gene which encodes calcium-responsive
transactivator (CREST) protein. Subsequently two add-
itional mutations in CREST, this time in patients with
familial form of ALS, were reported [5]. CREST is a
nuclear protein discovered in 2003 in a screen for calcium-
responsive genes involved in transcriptional activation [6].
The same year the gene encoding CREST was independ-
ently described as translocated in some cases of synovial
sarcoma [7]. CREST is important for normal development
of the nervous system, and CREST-deficient mice dis-
play defective dendritic branching, motor disturbances
and early lethality [6]. Importantly CREST interacts with
CREB-binding protein (CBP), a histone acetylase known
for its neuroprotective properties [8]. In the original study
CREST was also shown to bind chromatin remodeling
proteins BAF250 and BRG-1 [6]. Subsequently it was
demonstrated that CREST and a highly homologous pro-
tein, SS18, are dedicated subunits of chromatin remodel-
ing complex Brg/Brm-associated factor (BAF), which is an
important modulator of transcription of specific gene sets
at various stages of neural development [9]. Mutations in
components of the BAF complex have been identified in
autism, schizophrenia and other neurodevelopmental dis-
orders, arguing that its function is crucial for normal de-
velopment of the nervous system [10,11].
Structurally, CREST consists of a C-terminal transacti-
vation domain, which is characterized by low sequence
complexity and satisfies the criteria for a prion-like do-
main [4,6]; an N-terminal autoregulatory domain, which
suppresses transactivation at basal state [6]; a central
methionine-rich domain, and so called multifunctional
domain (MFD) implicated in the protein dimerisation,
regulation of transactivation and subcellular localization
of the protein [12]. In the nucleus, CREST was shown
to be recruited to nuclear bodies of unknown origin [13].
More recently, CREST was identified in a screen for para-
speckle proteins [14].
The majority of ALS-associated proteins are character-
ized by high aggregation propensity, which is attributable to
the presence of a prion-like domain in their structure [15].
The ability to aggregate reversibly is indispensable for their
normal function in RNA-protein macromolecular com-
plexes, such as RNA transport granules, stress granules,
paraspeckles and Gems; at the same time, pathological ag-
gregation of these proteins is also governed by prion-like
domains [16,17]. Despite the confirmed presence of a
prion-like domain in CREST structure, the aggregation pro-
pensity of wild type CREST and its ALS-associated variants
has not been addressed. Furthermore, dysfunction of para-
speckles/paraspeckle proteins has recently emerged as pos-
sible pathogenic factor in ALS [18,19]. The role of CREST
in the paraspeckle is not clear, nor is it known if the proteincan be recruited to other RNP complexes. Thus far, it
has been shown that an ALS-associated CREST muta-
tion leading to the deletion of the 9 C-terminal amino
acids, Q388stop [4], abolishes its binding to CBP, suggest-
ing that the missing amino acids act as an interface for
interaction between the two proteins [6]. Both Q388stop
and a mutation in autoregulatory domain, I123M, reduce
depolarization-induced branching in cultured neurons [4].
In vivo effects of the other two mutations involving MFD
and methionine-rich domain [5] have not been examined.
Therefore, in current study we aimed to characterize
the aspects of CREST structure and interactions relevant
to ALS pathogenesis in vitro and in vivo, primarily its
aggregation propensity and possible involvement in the
formation of nuclear and cytoplasmic RNA granules.
Results
CREST protein is prone to form aggregates in the cell
nucleus
Previous studies have demonstrated that in transfected
cells exogenous CREST localizes to nuclear dot-like struc-
tures designated as nuclear bodies [12]; however their
identity has not been determined. We generated constructs
to express either untagged CREST or CREST tagged with
GFP or Flag peptide. All three proteins displayed predom-
inantly nuclear distribution in neuroblastoma SH-SY5Y
and COS7 cells (Figure 1A, Additional file 1: Figure S1). In
agreement with the results of the above study, we also
observed formation of nuclear dot-like structures upon
expression of tagged or untagged CREST (Figure 1A,
Additional file 1: Figure S1). In cells with profound accu-
mulation of CREST in the nucleus, the presence of the
expressed protein in the cytoplasm and its cytoplasmic ag-
gregation were also evident, particularly for CREST-GFP
(Figure 1A, large + cyt panel, Additional file 1: Figure S1).
To establish if nuclear dot-like structures formed by
CREST were related to known nuclear bodies, transfected
cells were co-stained for various nuclear body markers. In
SH-SY5Y cells with a diffuse/fine-granular nucleoplasmic
distribution of CREST-GFP the protein was excluded from
nucleolar region identified by ethidium bromide staining,
was not enriched in SMN-positive Gems, coilin p80-
positive Cajal bodies or PML bodies but we detected its
enrichment around MALAT1-positive nuclear speckles
(Figure 1B). CREST was reported to be a paraspeckle
component [14]; we also observed CREST-GFP enrich-
ment in paraspeckles visualized by NEAT1 FISH, but only
in cells with low levels and diffuse distribution of the pro-
tein (Figure 1B, bottom panel). Large dot-like nuclear struc-
tures formed by CREST did not overlap with any of the
above nuclear bodies, including paraspeckles, though they
often surrounded speckles (Figure 1C). Hereafter, these nu-
clear structures as well as cytoplasmic CREST accumula-
tions of any appearance will be referred as “aggregates”.
Figure 1 CREST protein is aggregation-prone in vivo. (A) CREST aggregates upon its accumulation in the nucleus. GFP-tagged, Flag-tagged or
untagged CREST are largely confined to the nucleus where they are diffusely distributed or can form dot-like aggregates. In high-expressing cells
CREST aggregates are visibly larger and the protein undergoes a shift to the cytoplasm where it also aggregates (‘large + cyt’ panel). SH-SY5Y cells
expressing tagged or untagged CREST were analysed 24 hours post-transfection. (B) CREST-GFP is almost entirely confined to the nucleus where
it is excluded from the nucleolus visualised by ethidium bromide (EtBr) staining. It is not enriched in PML bodies (anti-PML staining), Gems
(anti-SMN staining) or Cajal bodies (anti-coilin p80 staining), but is concentrated around speckles (FISH with MALAT1 probe) and highly
enriched in paraspeckles (FISH with NEAT1 probe) in low-expressing cells. (C) Nuclear aggregates formed by CREST-GFP overexpressed in
SH-SY5Y cells do not overlap with PML bodies, Gems, Cajal bodies or paraspeckles but surround speckles. Arrowheads denote nuclear
bodies in CREST-expressing cells. Scale bars, 10 μm.
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tagged CREST [14], GFP-tagged, Flag-tagged and un-
tagged CREST also redistributed to nucleolar caps in
actinomycin D-treated cells expressing low levels of
CREST (Figure 2A and data not shown). We argued that
if dot-like CREST structures are stable, irreversibly ag-
gregated entities they will not be affected by transcrip-
tional arrest. Indeed, preformed nuclear aggregates of
CREST remained intact following actinomycin D treat-
ment (Figure 2B), although formation of weakly CREST-
positive nuclear caps could be observed, probably due
to protein redistribution from the pool of not yet ag-
gregated protein (Figure 2B, arrowheads). Using live cell
imaging, we also demonstrated that nuclear CRESTaggregates are characterized by time- and concentration-
dependent fusion and growth (Additional file 2: Video S1).
To explore CRESTaggregation biochemically, we expressed
untagged protein with subsequent sequential extraction
in detergent-containing buffers (see Methods section
for details). As shown in Figure 2C, approximately 10% of
CREST remained in the TritonX-100/RIPA-insoluble
fraction which could only be solubilised by boiling in
the presence of 4% SDS. However, similar to some other
ALS-associated proteins that form non-amyloid aggregates,
neither tagged nor untagged CREST formed SDS-resistant
amyloidogenic species, as was evident from detection of
only monomeric forms of the protein in semidenaturating
detergent agarose gel (SDD-AGE) assay (Figure 2D).
Figure 2 Characterisation of the aggregation capacity of CREST. (A) In cells with diffuse distribution of CREST, it re-localizes to nucleolar caps
(arrowheads) in response to transcriptional inhibition. (B) The pool of CREST in nuclear dot-like aggregates fails to redistribute to nucleolar caps
upon inhibition of transcription, and the aggregates persist under these conditions, although weakly CREST-positive nuclear caps can be observed
(arrowheads). In A and B SH-SY5Y cells were exposed to actinomycin D for 1 hour. (C) CREST is recovered in detergent-insoluble fractions. HEK293
cells expressing untagged CREST were subjected to sequential protein extraction as described in Materials and methods. For total lysate (L) and
high-salt (HS) fraction 10% of the amount relative to other fractions was loaded. Bar chart shows relative protein amounts (±s.e.m.) in each frac-
tion quantified by densitometry. (D) Untagged CREST, Flag-CREST and GFP-CREST do not form SDS-resistant oligomeric forms. Cleared lysates of
CREST-expressing SH-SY5Y cells were run in SDS-containing agarose gel; all variants were visualized using anti-CREST antibody. Mutant tau protein
from spinal cord lysate of a transgenic P301S mouse (detected by phospho-tau-specific antibody) was used to demonstrate typical behavior of
amyloid species in this assay. (E) Schematic representation of CREST deletion constructs used in the study. All variants were expressed as GFP-
fusion proteins. (F, G) Distribution of CREST deletion mutants in SH-SY5Y cells. CR_dNT and CR_dNT-Met were shifted to the cytoplasm and
formed nuclear dot-like aggregates less frequently than full-length protein (G). Bar chart in G shows the fraction of cells (mean ± s.e.m.) with nu-
clear aggregates for each variant (*** - p < 0.001; at least 150 cells counted per variant in each of the three independent experiments). CREST was
expressed for 24 hours prior to actinomycin D exposure, cell lysis or fixation. Scale bars, 10 μm.
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to its aggregation propensity, we produced a set of deletion
constructs tagged with GFP at their N-terminus (Figure 2E)
and expressed them in SH-SY5Y cells (Figure 2F). N-
terminal autoregulatory domain (CR_NT) or C-terminal
part of CREST (CR_CT) in isolation did not aggregate
and were present both in the nucleus and in the cyto-
plasm. Deletion of C-terminal part completely abolished
the protein’s ability to aggregate. In contrast, CREST lack-
ing the autoregulatory domain only (CR_dNT) or in
combination with Met-rich domain (CR_dNT-Met) was
distributed and aggregated in a very similar manner to
the full-length protein, i.e. these variants were detected
mainly in the nucleus where they formed multiple puncta
(Figure 2F). However, for these two variants, cytoplasmicdelocalisation was more pronounced and aggregation
capacity was diminished compared to full-length CREST
(Figure 2F,G). The middle region of CREST comprising
Met-rich and MFD domains (CR_dNT-CT) was efficiently
targeted to the nucleus where it accumulated inside the
nucleolus. Deletion of MFD domain rendered the protein
highly aggregation-prone, and this variant was found al-
most exclusively in the form of aggresome-like cytoplasmic
aggregates (Figure 2F). Co-expression of two complemen-
tary variants both displaying diffuse cellular distribution,
CR_dCT and CR_CT, was not sufficient to trigger aggre-
gation (Figure 2F), suggesting that this process requires the
presence of the domains in cis. Therefore, both N-terminal
and C-terminal parts of CREST are required for efficient
aggregation, while central MFD might limit it.
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A growing number of ALS-associated proteins have
been shown to be the components of stress granules
(SGs), cytoplasmic RNP foci assembled by cells in re-
sponse to adverse conditions and facilitating transla-
tional shutdown under severe stress [20]. We examined
CREST behaviour under various stresses and showed
that CREST is also a resident of SGs. SH-SY5Y cells ex-
pressing full-length CREST-GFP or CREST-Flag were
exposed to sodium arsenite, thapsigargin or a prosta-
glandin 15d-PGJ2 to trigger SG formation by inducing
oxidative stress, ER stress or inhibiting translation elong-
ation factor eIF4E [21], respectively. In cells with small
aggregates or diffuse staining in the nucleus all three
stimuli led to weak but reproducible CREST recruitment
to SGs visualised with SG markers TIAR, G3BP1 or
FMRP (Figure 3A), which was facilitated by the emergence
of typically nuclear CREST in the cytoplasm of stressed
cells (Figure 3B). Only two CREST deletion mutants –
those lacking N-terminal domains, namely CR_dNT and
CR_dNT-Met, – were recruited in SGs, moreover, they
were detected at higher levels within SGs compared to the
full-length protein (Figure 3C,D and data not shown). This
was likely due to their cytoplasmic redistribution rather
than enhanced propensity for SG recruitment since fluor-
escence intensity ratio SG/cytoplasm was similar for
CR_dNT and full-length protein (Figure 3D). It was not
possible to establish if CR_dMFD was recruited to SGs
due to its high aggregation propensity. These results indi-
cate that CREST recruitment to SGs is restricted by its
limited occurrence in the cytoplasm and that the presence
of C-terminal domain (CT, aa. 317-396) and MFD is ne-
cessary and sufficient for SG targeting of CREST.
Cytoplasmic aggregates of full-length CREST-GFP ob-
served in a fraction of cells that also display large nu-
clear aggregates (similar to illustrated in Figure 1A) were
negative for SG or P-body markers under basal condi-
tions or after stress, although in stressed cells these ag-
gregates were found in the vicinity of SGs (Figure 3E,F).
Large cytoplasmic aggregates formed by CR_dMFD pro-
tein also did not contain core SG proteins even in stressed
cells (Figure 3G).
CREST aggregation affects paraspeckles
Dysfunction of the paraspeckle has been recently impli-
cated in pathogenesis of ALS [18,19]. Although the role
of CREST in this nuclear body is not clear, it is unlikely
to be essential for paraspeckle assembly because the ma-
jority of stable cell lines display normal paraspeckles
despite very low levels of CREST expression. To further
examine the involvement of CREST in these nuclear
bodies, we used COS7 cells, which possess prominent
paraspeckles. In the majority of cells displaying nuclear
dot-like aggregates of CREST-Flag, these structures wereclearly distinct from paraspeckles visualized by staining
for a core paraspeckle protein NONO/p54nrb (Figure 4A,
top panel). However, careful examination revealed that a
fraction of CREST aggregates was adjacent to paraspeckles
(Figure 4A, bottom panel). Consistently, similar to para-
speckles, these aggregates are often seen on the border of
speckles (Figure 1C). Therefore, sites of paraspeckle as-
sembly might serve as sites of nucleation of CREST aggre-
gates that radiate from paraspeckles and subsequently
become scattered in the nucleoplasm. CREST behaves as
a typical paraspeckle protein upon transcriptional repres-
sion, i.e. becomes recruited to nucleolar caps (Figure 2A)
and Ref. [14]). These nucleolar caps match those formed
by other paraspeckle proteins such as FUS, and are dis-
tinct from nucleolar caps formed by coilin p80 (Figure 4B).
Furthermore, CREST deletion variants lacking an autore-
gulatory domain, CR_dNT and CR_dNT-Met, unlike other
deletion mutants, are highly enriched in paraspeckles re-
gardless expression levels and can be readily recruited to
actinomycin D-induced nucleolar caps (Figure 4C and data
not shown).
We next asked if CREST is able to recruit other para-
speckle proteins into its nuclear aggregates. Indeed, a
core paraspeckle component, FUS, was efficiently se-
questered into virtually all nuclear aggregates formed by
CREST-Flag or CREST-GFP regardless their size and
abundance (Figure 4E, Additional file 3: Figure S2B).
However, FUS is not essential for CREST aggregation,
since siRNA-mediated FUS knockdown did not affect
nuclear aggregate formation by CREST-Flag (Figure 4D).
Other major paraspeckle proteins, NONO/p54nrb and
PSPC1, were not detected in small CREST aggregates
(Figure 4F,G, top panels) but co-aggregated with CREST
in those nuclei where most of CREST pool was present in
the form of larger aggregates (Figure 4F,G, bottom panels).
These observations suggest that FUS recruitment to
CREST aggregates is highly specific while NONO/p54nrb
and PSPC1 can be non-specifically trapped in these aggre-
gates upon their growth. Since FUS is essential for para-
speckle integrity and contributes to the maintenance of
NEAT1 levels [14,19], its entrapment in aggregates can
negatively affect paraspeckles, including via NEAT1 down-
regulation. Indeed, COS7 cells expressing CREST-Flag
and developing nuclear aggregates, contained paraspeckles
(visualised with anti-NONO/p54nrb staining) less fre-
quently than cells with diffuse protein only (Figure 4I).
Similarly, among CREST-GFP expressing COS7 cells
significantly fewer aggregate-containing cells possessed
NEAT1-positive paraspeckles compared to non-transfected
cells or cells with diffuse CREST distribution (Figure 4H,I).
Furthermore, when we measured NEAT1 levels in neuro-
blastoma cells expressing untagged CREST or GFP vector,
we observed a significant decrease in the transcript abun-
dance in CREST-expressing cells (Figure 4J).
Figure 3 CREST is targeted to stress granules by various stresses. (A) CREST-Flag (top panel) and CREST-GFP (three bottom panels) are detected
in stress granules induced by oxidative stress (sodium arsenite, SA), ER stress (thapsigargin, thaps) or inhibition of eIF4E (15d-PGJ2) and visualized with
stress granule markers TIAR, FMRP and G3BP1. SA and 15d-PGJ2 were applied to SH-SY5Y cells for 1 hour and thapsigargin – for 4 hours. (B) In SH-SY5Y
cells subjected to oxidative stress (SA for 1 hour) CREST-GFP undergoes significant shift to the cytoplasm. (C, D) CREST deletion mutant lacking
autoregulatory domain (CR_dNT) is readily recruited to stress granules (C) and shows higher enrichment in these structures compared to
full-length protein (D, left graph). This phenomenon is related to higher cytoplasmic levels of CR_dNT since the fluorescence intensity ratio
stress granules/cytoplasm is similar for full-length and truncated protein (D). (E) Cytoplasmic aggregates of CREST-GFP do not overlap with SA-induced
stress granules but are found in their immediate vicinity. (F) Cytoplasmic aggregates of CREST-GFP do not overlap with P-bodies (visualized
by anti-Dcp1a staining, arrowheads in the enlarged panel). (G) Aggresomes formed by GFP-tagged CREST lacking MFD domain are negative
for a SG marker G3BP1. In B and D, fluorescence was measured in stress granules and/or cytoplasm of GFP-positive cells as described in Materials and
methods, and cytoplasmic intensity for non-stressed cells (B) or full-length CREST-GFP (D) (mean ± s.e.m.) was taken as equal 1 (***p < 0.001). Scale
bars, 10 μm.
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Figure 4 CREST aggregation disrupts paraspeckles. (A) CREST aggregates might originate from the sites of paraspeckle formation. Paraspeckles
(anti-NONO/p54nrb staining, arrowheads) and CREST nuclear aggregates exist as distinct structures in COS7 cells (top panel). In a fraction of cells
CREST aggregates are found in close apposition to/partially overlapping with paraspeckles (bottom panel). (B) In response to transcriptional
inhibition CREST redistributes to the same nucleolar caps as a typical paraspeckle protein FUS but not to the caps formed by coilin p80. (C) CREST
lacking autoregulatory domain is efficiently recruited in paraspeckles (top panel) and redistributes to nucleolar caps (bottom panel). (D) Endogenous
FUS is not essential for nuclear aggregation of CREST. Cells were co-transfected with FUS siRNA and a plasmid to express CREST-Flag and were
analysed 48 hours post-transfection. (E-G) CREST efficiently sequesters endogenous FUS into dot-like nuclear aggregates in COS7 cells. In contrast,
two other paraspeckle components, p54nrb and PSPC1, are not recruited to small and medium-sized CREST aggregates (F and G, top panels), and are
detected in aggregates only in nuclei with extensive CREST aggregation (F and G, bottom panels). (H, I) Presence of CREST aggregates in the nucleus
negatively affects paraspeckles. The fraction of cells with paraspeckles among COS7 cells expressing CREST-Flag (anti-p54nrb staining) or CREST-GFP
(FISH with NEAT1 probe) was quantified separately for cells with diffuse CREST distribution and with nuclear CREST aggregates (mean ± s.e.m, *p <
0.05, **p < 0.01; 150-250 cells counted from each of the four or three independent experiments). (J) NEAT1 levels are decreased in CREST-expressing
cells. Untagged CREST or GFP (vector) were expressed in SH-SY5Y cells for 24 hours; NEAT1 levels were measured by qPCR (**p < 0.01; results from four
independent experiments run in duplicates). Scale bars, A – 5 μm; B-G – 10 μm.
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proteins TDP-43 or TAF15
Previously reported results of co-immunoprecipitation
experiments demonstrated that two ALS-associated pro-
teins, CREST and FUS, interact in vivo [4]. However, we
identified a significant cross-reactivity of the anti-CREST
antibody used in the above study with FUS protein
(Additional file 4: Figure S3). Nevertheless, we also found
that endogenous FUS is efficiently recruited into nuclearCREST aggregates (Figure 4E). To confirm CREST-FUS
interaction in vivo, we transfected cells with a con-
struct to express CREST-GFP and performed immuno-
precipitation using GFP-Trap beads. Endogenous FUS
was co-immunoprecipitated with CREST in this cellu-
lar system indicating that the proteins indeed interact
in vivo (Figure 5A).
We went on to study FUS-CREST co-aggregation in
more detail and establish if it is specific for FUS. Co-
Figure 5 CREST co-aggregates with FUS but not with TDP-43 or TAF15. (A) Endogenous FUS co-immunoprecipitates with CREST-GFP. Pull-down
of GFP-tagged CREST from transfected cells was performed with GFP-Trap beads as described in Material and methods, endogenous FUS was detected in
the immunoprecipitate (IP) by Western blotting (WB). (B) CREST-Flag recruits GFP-tagged FUS (top panel) and its cytoplasmically mislocalised variant
bearing R522 substitution (FUS R522G, middle panel) into nuclear aggregates upon co-expression in SH-SY5Y cells. In a small fraction of co-expressing
cells the latter variant also co-aggregates with CREST in the cytoplasm (middle, arrowheads, border of the nucleus is indicated by a dashed line in the
inset) but in the majority of such cells it is trapped in the nucleus leading to its lowered cytoplasmic levels and significant decrease in the proportion
of cells bearing cytoplasmic FUS aggregates (FAs, bottom panel). The number of cells with aggregates was quantified for cells expressing GFP-tagged
FUS R522G only (FUS-GFP) and those co-expressing GFP-tagged FUS R522G and CREST-Flag (FUS + CREST). The bar chart shows the fraction of cells
(mean ± s.e.m.) bearing FAs (***p < 0.001; at least 100 cells counted per variant from three independent experiments). (C) CREST-GFP and FUS-Flag with
R522G substitution co-aggregate. (D) N-terminally truncated protein (FUS-GFP CT, aa. 360-526) cannot be recruited to CREST-Flag aggregates (top
panel), while C-terminally truncated FUS (FUS-GFP NT, aa.1-359) retains the ability to co-aggregate with CREST (bottom panel). (E) CREST does not
sequester wild-type TDP-43 into nuclear aggregates and is not recruited to cytoplasmic (arrow) or nuclear (arrowheads) aggregates formed by
mislocalised TDP-43 (TDP-43-GFP dNLS) or C-terminal TDP-43 fragment (TDP-43-GFP CT, aa.193-414). NLS of TDP-43 was deleted to achieve
cytoplasmic re-distribution and aggregation of the protein. (F) Nuclear aggregates of Flag-tagged CREST and GFP-tagged TAF15 do not
overlap. Scale bars, 10 μm.
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robust co-aggregation in the nucleus (Figure 5B, top
panel), seemingly, via sequestration of FUS into dot-like
CREST aggregates. This was also true for cytoplasmically
mislocalised FUS mutant bearing a substitution in its
nuclear localisation signal, FUS R522G (Figure 5B, middle
panel). Although R522G mutation leads to dramatic shift
to the cytoplasm and subsequent cytoplasmic aggregationof FUS [22,23], when co-expressed with CREST-Flag,
FUS-GFP R522G was present in the cytoplasm at low
levels and the percent of cells bearing cytoplasmic FUS ag-
gregates was significantly decreased (Figure 5B, bottom
panel). We concluded that aggregating CREST-Flag is
able to recruit and retain FUS in the nucleus leading
to its lowered cytoplasmic levels and interfering with its
cytoplasmic aggregation. Interestingly, cells that formed
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pressed CREST within those aggregates (Figure 5, middle
panel, arrowheads). Similarly, CREST-GFP co-aggregated
with FUS-Flag R522G (Figure 5C). The region respon-
sible for co-aggregation of FUS with CREST lies in the
N-terminal part of the FUS molecule, since a variant lack-
ing all domains downstream of the RRM (NT-RRM,
aa. 1-359) was still able to co-aggregate with CREST, but
no recruitment into CREST aggregates was observed for
the C-terminal FUS fragment (CT, aa.360-526) (Figure 5D).
In contrast, neither normal TDP-43, nor TDP-43 ren-
dered cytoplasmiс by deletion of its NLS, nor C-terminal
TDP-43 fragment (aa.193-414), showed co-aggregation
with CREST (Figure 5E). Furthermore, aggregates formed
in the nucleus by another ALS-associated protein struc-
turally highly similar to FUS, TAF15, were clearly distinct
from nuclear CREST aggregates (Figure 5F).
Q388stop mutation alters steady-state levels and aggre-
gation propensity of CREST protein
Recently four mutations were identified in CREST in
ALS patients [4,5]. However, the basis of their pathogen-
icity is still not clear. The mutations do not cluster but
are spread along the molecule, each found in a different
domain (Figure 6A). We created constructs for the ex-
pression of these four variants as untagged proteins. The
proteins displayed predominantly nuclear distribution
indistinguishable from the wild-type protein (Figure 6B).
All variants occasionally formed nuclear dot-like aggre-
gates similar to those shown in Figure 1A for untagged
wild-type CREST; the frequency of cells bearing such
aggregates was comparable between the variants ex-
cept Q388stop, a mutant lacking eight amino acids at
its C-terminus. The latter aggregated in the nucleus
significantly more often than wild-type protein or any
other studied mutant (p = 0.0169; Figure 6C). All
CREST variants were expressed in cell lines studied at
similar levels, however, densitometric analysis revealed
that steady-state levels of Q388stop variant were elevated
(p = 0.0483) compared to other variants despite insignifi-
cant differences at mRNA level (Figure 6D). To assess if
CREST mutations alter protein stability, we estimated the
proteins’ half-lives using a pulse chase with cycloheximide.
Overexpressed CREST was stable, with half-life of ap-
proximately 36 hours, without significant differences
between the variants but again with the exception of
Q388stop, which displayed increased stability (Figure 6E).
The propensity of CREST mutants to aggregate was
estimated using the sequential extraction protocol de-
scribed above. All variants behaved very similarly to
the non-mutated CREST without marked changes in the
abundance in different fractions (Figure 6F). We did
not observe any differences between the mutants in
their ability to be recruited to SGs or paraspeckles, orco-aggregate with FUS protein (Figure 6G, Additional
file 3: Figure S2).
CREST overexpression negatively affects dendritic
complexity in cultured hippocampal neurons and causes
retina degeneration in transgenic Drosophila
In a previous study an inhibitory effect of mutant
CREST variants Q388stop and I123M on KCl-induced
neurite outgrowth in cultured mouse cortical neurons
has been reported [4]. Because CREST is prone to aggre-
gation and sequesters some important proteins into ag-
gregates, it is feasible that its overexpression per se
might be deleterious to neurons. We therefore examined
the effect of normal CREST and its mutants on the com-
plexity of dendritic tree in unstimulated primary mouse
hippocampal neurons. In these cells both GFP-tagged
and untagged CREST displayed similar distribution with
mainly nuclear localization, and frequent aggregation in
the nucleus and occasionally in the processes (Figure 7A);
aggregation increased in a concentration-dependent
manner. Untagged CREST was used for further analysis
due to its more physiological nature. Hippocampal neu-
rons isolated from mice on postnatal day 3 and cultured
for 5 days were co-transfected with a vector for GFP ex-
pression to visualise neuronal morphology, and each of the
CREST variants. The cells were allowed to express the pro-
teins for 48 hours (see Methods for details). Total dendritic
length was significantly decreased in CREST-expressing
neurons compared to neurons transfected with vector only
and was comparable between the variants (Figure 7B). How-
ever, this parameter was lower (p = 0.049983) for Q388stop
variant compared to wild-type CREST (Figure 7B). Simi-
larly, CREST-expressing cells exhibited fewer dendritic
trees, and for Q388stop and to a lesser extent A264T, this
effect was even more pronounced than for wild-type pro-
tein (Figure 7B). Sholl analysis of CREST expressing neu-
rons also revealed a significant difference only for the
Q388stop mutant: the number of shell intersections for
neurons expressing this protein was significantly lower
compared to that for wild-type protein (Figure 7C).
To address possible effects of elevated CREST levels
in vivo, we generated Drosophila melanogaster lines over-
expressing untagged normal or mutant human protein
using GAL4-UAS system (Additional file 5: Figure S4,
Figure 8A). UAS-CREST wild-type, I123M and Q388stop
transgenic lines were crossed with gmr-GAL4 line to drive
the expression of proteins in the retinal photoreceptor
neurons. External morphology of the heads of 5-day-old
flies overexpressing these variants was characterized by
rough and de-pigmented eyes compared to those overex-
pressing lacZ as a control protein, without obvious differ-
ences between the lines (Figure 8B). Histological analysis
revealed marked disruption of the regularly ordered arrays
of photoreceptor neurons with thinned retina (Figure 8C).
Figure 6 ALS-associated CREST mutation Q388stop increases steady-state levels of the protein and its ability to aggregate. (A) A map
of CREST with the positions of single amino acid substitutions or a deletion found in ALS indicated. (B) All CREST variants are localized
predominantly to the nucleus in SH-SY5Y cells. (C) Q388stop mutant aggregates in the nucleus more often compared to the normal protein and
other mutants. Among cells expressing each of the untagged CREST variants those with aggregates in the nucleus were quantified on the entire
coverslip 24 hours post-transfection and obtained values were normalized against the value for wild-type CREST. The bar chart shows
means ± s.e.m. of these normalized values from four independent experiments (*p < 0.05). (D) Steady-state protein levels for Q388stop
mutant variant are increased compared to the wild-type protein without significant difference at the transcript level. The bar charts show means ±
s.e.m. of seven independent experiments (*p < 0.05, Mann-Whitney U-test). (E) All CREST variants are stable proteins with half-lives of approximately 36
hours. Cycloheximide was used to block protein synthesis; levels of a short-lived protein, cyclin A, were measured to confirm successful block
of translation. (F) Solubility of mutant CREST variants upon sequential protein extraction was comparable to that of wild-type protein.
Fractionation was performed as described in Materials and methods. (G) CREST mutants do not affect the ability of the protein to be recruited to
stress granules. The fraction of cells with CREST-positive stress granules after sodium arsenite exposure was quantified in the population of CREST-GFP
expressing cells for each variant (at least 100 cells counted per variant in each of the two independent experiments). Scale bar, 10 μm.
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Figure 7 Overexpression of normal or mutant CREST affects complexity of dendritic tree in primary hippocampal neurons. (A) CREST-GFP is
largely confined in the nucleus when expressed in primary mouse neurons but is also found in multiple dot-like aggregates in the processes in some
cells. Untagged CREST displays nuclear distribution in neurons. CREST-GFP or untagged CREST was co-transfected into primary hippocampal neurons
together with dsRed2 to visualise neuronal morphology and allowed to express for 48 hours prior to analysis. (B) Total dendritic length in micrometers
measured in mouse hippocampal neurons expressing CREST variants. Mouse primary hippocampal neurons were co-transfected with vectors
to express GFP (to visualize neuronal morphology) and each of the untagged CREST variants and allowed to express the proteins for
48 hours prior to analysis. Control neurons were transfected with GFP-expressing vector only. The bar charts show means ± s.e.m. for at
least 100 neurons per variant from four independent experiments (*p < 0.05, ***p < 0.001). (C) Sholl analysis of the same neurons as in B.
Number of dendrite intersections of 15-μm spaced shells as a function of the radial distance from the soma was plotted. **p < 0.01,
***p < 0.001. Scale bar, 50 μm.
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in photoreceptor neurons of a fly is sufficient to induce se-
vere degeneration.
Discussion
Our study presents evidence that CREST possesses three
properties common to several proteins associated with
ALS: i) high propensity to aggregate in cells; ii) recruit-
ment into stress granules; and iii) ability to modulate
paraspeckle integrity. There is a growing body of evi-
dence that protein aggregation and altered function of
SGs (and likely, paraspeckles) are important factors in
ALS pathogenesis, and our observations also point to
these processes as potential culprits for the development
of pathological changes in ALS cases with CREST
mutations.
In the previous studies devoted to cellular localization
and functions of CREST it has been proposed that nu-
clear structures formed by CREST represent a type of
nuclear body that recruits CBP protein and thereby reg-
ulates its functions [13]. Here we show that CREST
structures appearing upon protein accumulation in the
nucleus correspond to irreversibly aggregated entities
formed due to the high aggregation propensity of CREST,
since they grow in time- and concentration-dependentmanner and do not dissipate in response to transcriptional
repression like genuine nuclear bodies, paraspeckles and
Cajal bodies [24,25]. In line with this, CREST accumulates
in detergent-insoluble fractions when overexpressed in
cultured cells. It cannot be ruled out that at early stages of
their formation, nuclear CREST aggregates represent
physiologically relevant and functional foci recruiting fac-
tors such as CBP to certain genome locations. However, in
certain conditions CREST in these foci may start aggregat-
ing uncontrollably thereby transforming them into patho-
logical aggregates. This can be caused by abnormally high
accumulation of CREST in the nucleus and, consequently,
in the foci, or by lower concentration threshold of un-
controllable aggregation for mutated CREST. A simi-
lar scenario has been suggested for transformation of
cytoplasmic RNA granules enriched in proteins with
prion-like domains into proteinaceous inclusions in pro-
teinopathies [22,23]. CREST also has a prion-like domain
in its structure, and the latter was proposed to play a
role both in physiological and pathological aggregation
[15-17]. Since at present the nature of these CREST struc-
tures is unclear, in this study they are collectively referred
as “aggregates” regardless their physiological significance.
It should be kept in mind that accumulation of very high
levels of the protein observed in some cells upon its
Figure 8 Overexpression of normal or mutant CREST induces retinal degeneration in Drosophila melanogaster. (A) Protein expression
levels of CREST variants in the heads of transgenic flies of each line as determined by Western blotting and subsequent quantification of band
intensities (mean ± s.d). (B) Images of external head surface of 5-day-old flies overexpressing wild-type CREST, CREST I123M, CREST Q388stop or
lacZ in the retina. Overexpression of wild-type CREST or its variants in photoreceptor neurons results in rough and depigmented eyes. (C) H&E
staining of retinal sections of 5-day-old flies overexpressing wild-type CREST or its variants reveals disruption of regularly ordered arrays of
photoreceptor neurons. Data for representative transgenic fly lines with similar (intermediate) level of CREST protein expression are shown
(#7, #7 and #2 for WT, I123M and Q388stop variants, respectively, – see Additional file 5: Figure S4). Scale bar, 50 μm.
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ous protein. However, in our study nuclear CREST aggre-
gates started appearing already in cells with low levels
of exogenous protein indicating a low threshold for its
multimerization. Further studies using more physiological
models, such as neurons differentiated from iPS cells of
patients with CREST mutations or cells with modified
CREST gene, are required to establish the molecular
nature of CREST aggregates at different stages of their
formation as well as functional relevance of CREST
multimerization.
It has been shown previously that the N-terminal
autoregulatory domain of CREST is largely dispensable
for its localization to nuclear aggregates [13] however we
also noted that the CR_dNT mutant lacking this domain
has diminished aggregation propensity. Interestingly, un-
like similar domains of FUS and TDP-43 [26-28], the
C-terminal transactivation domain of CREST cannot ag-
gregate in isolation despite its prion-like properties. Thus,
the aggregation propensity of CREST is defined by co-
operative action of its C-terminal and N-terminal do-
mains, while MFD may limit it. Importantly, in our study
only CREST deletion variants with preserved ability toaggregate were capable of SG and paraspeckle recruit-
ment. This correlation provides further support for the
notion that the ability of proteins bearing a prion-like do-
main to aggregate reversibly (i.e. “physiological” aggrega-
tion) is prerequisite for their entry into RNA granules
such as SGs and paraspeckles [15-17]. Seemingly, such
proteins have to be tightly regulated, and modulation of
CREST aggregation propensity by autoregulatory domain
and MFD is an example of such regulation. Even subtle
changes in the structure of such domains may lead to
uncontrollable aggregation and downstream events dele-
terious for neurons. We also demonstrated that both auto-
regulatory domain and MFD of CREST contribute to
nuclear localization of the protein. Impairment of these
domains’ function may therefore result in cytoplasmic re-
distribution of the protein, similar to redistribution of FUS
bearing ALS-linked mutations in its nuclear localization
signal [22,23].
We also showed that nuclear aggregates of CREST are
able to trap certain proteins such as FUS, which could lead
to loss of their function. Therefore, changes in CREST
levels (e.g. due to increased stability) or its solubility, trig-
gered by any external or internal factor including mutation,
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system, which in turn would affect CREST binding part-
ners important for neuronal homeostasis. There are sev-
eral reports of increased stability [29-31] and/or higher
aggregation propensity [28,32,33] of ALS-associated TDP-
43 mutants compared to non-mutated protein. Similarly,
we have demonstrated that at least one of the ALS-linked
mutations in CREST, Q388stop, affects protein stability
and renders it more aggregate-prone. An opposite situ-
ation, where CREST would be sequestered into aggregates
formed by other proteins, particularly FUS, is also pos-
sible. Our attempts to establish if CREST pathology is
present in FUSopathies were precluded by cross-reactivity
of the anti-CREST antibody, suitable for histological
staining, with FUS. When a truly specific antibody be-
comes available it would be interesting to determine the
extent of CREST involvement in histopathology typical of
FUSopathies.
Altered metabolism of SGs is now widely acknowl-
edged to be contributory to ALS pathogenesis [3,34-38],
and recently dysfunction of another RNA granule, the
paraspeckle, has emerged as a possible factor in ALS path-
ology. Paraspeckles are built on a long non-coding RNA
NEAT1 and recruit a subset of proteins, including FUS
and to a lesser extent TDP-43 [14]. Functionally, this RNA
granule is involved in the nuclear retention of specific
RNAs [39], regulation of gene expression and possibly the
cellular stress response [40,41]. Results of several studies
suggest a role for paraspeckle proteins and NEAT1 in
ALS/FTLD disease pathogenesis [42-49]. Furthermore, it
has been specifically demonstrated that paraspeckle as-
sembly triggered by upregulated NEAT1 synthesis occurs
in motor neurons at the early stage of ALS development,
suggesting a protective role against various insults, which
might be particularly important for motor neuron welfare
[18]. We have also established links between loss and gain
of function of FUS protein and disrupted paraspeckle as-
sembly in ALS-FUS [19]. This allowed us to propose a
model whereby aggregation of FUS in the cytoplasm leads
to its nuclear loss accompanied by depletion of other
paraspeckle proteins, which in turn may disable protective
paraspeckle assembly and contribute to neurodegenera-
tion in FUSopathies. A similar scenario may occur in ALS
cases caused by CREST mutations, where aggregating pro-
tein can sequester FUS (and perhaps other paraspeckle
proteins) into aggregates and attenuate protective para-
speckle formation.
We observed no overt phenotypes specific to identified
ALS-associated CREST mutations except for Q388stop.
Instead, we showed that excess of CREST affects neuron
morphology independently of the presence of mutations.
Moreover, in transgenic fly models, all studied protein
variants, including non-mutated protein, were highly
toxic and induced severe retinal degeneration. Therefore,alterations of CREST stability and consequently, intracel-
lular protein level, which might occur as a result of muta-
tion or triggered by external factors, would be deleterious
for neurons, the only type of cells expressing high levels
of CREST. Q388stop mutation was predicted to be highly
damaging since it affects the prion-like domain and
removes a CBP-interaction motif of CREST [4]. We
showed that this mutation also increases steady-state pro-
tein levels, promotes CREST aggregation and perhaps as a
result, negatively affects branching and outgrowth of neur-
itis in cultured neurons. No gross differences in subcellular
localization, aggregation capacity, stability, SG/paraspeckle
recruitment or in vivo toxicity of other mutants compared
to wild-type protein were registered indicating the need for
fine structural and functional assays to further probe their
pathogenicity. The fact that alterations in the structure and
properties of CREST are not immediately recognizable
is not surprising as a similar trend was revealed in
the studies of mutant variants of other ALS-associated
proteins. For example, only some ALS-causative FUS vari-
ants with mutations in NLS are redistributed to the cyto-
plasm in cultured cells, whereas others do not visibly
affect nuclear import [50,51]. Similarly, prion-like and
glycine-rich domains of TDP-43 are the hot-spots of mu-
tations, but functional consequences of different muta-
tions in these domains are highly variable [51,52]. Studies
on post-mortem tissue of patients bearing mutations in
CREST would be highly informative for establishing if
CREST is indeed another protein whose aggregation leads
to neurodegeneration. CREST is essential for the nervous
system homeostasis as evidenced by the severe neuro-
logical phenotype of CREST deficient mice [6] as well
as its high expression levels specifically in postmitotic
neurons [9]. Therefore, it is highly likely that mutations
identified in ALS only slightly compromise the protein
structure allowing normal development of the nervous
system, but nevertheless are sufficient to trigger a severe
neurodegenerative disorder in the adulthood. Our stud-
ies in vitro and in vivo suggested that altered protein
stability and hence its increased levels may be behind
this effect. Interestingly, one ALS patient with CREST
mutation also carried an amino acid substitution in
OPTN gene [5]. It is plausible that in this case the pres-
ence of both mutations was necessary for manifestation
of the clinical phenotype, providing another example
in support of the emerging concept of ALS as an oli-
gogenic disease [53].
In summary, our study provides experimental evidence
that CREST can be considered another member of the
growing group of ALS-linked aggregation-prone proteins
capable of recruitment to SGs and other RNA granules.
Until very recently, members of this group were exclu-
sively RNA-binding proteins. However, together with the
report on profilin1 recruitment to SGs [54], our study
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components other than RNA-binding proteins.
Methods
Expression plasmids, stable cell lines, transfection and
treatments
DNA fragments encoding full-length CREST, FUS, TDP-43
and TAF15 and their deletion and mutant variants were
produced by RT-PCR amplification with SuperScript III
and AccuPrime polymerases (Invitrogen, Life Technologies)
from human (SH-SY5Y cells or fetal brain) total RNA
using respective primers and cloned into pCR-BluntII-
TOPO vector (Invitrogen, Life Technologies). After se-
quence validation the fragments were subcloned into the
pEGFP-C1 vector (Clontech) downstream and in-frame
with GFP to produce proteins bearing N-terminal GFP
tag; into the pEGFP-N1 vector (Clontech) upstream and
separated by a stop codon from GFP to obtain non-tagged
proteins; and into the pCMV4-Flag vector (Sigma) for the
expression of Flag-tagged wild-type CREST. SH-SY5Y,
HEK293 and COS7 cells were maintained in Dulbecco
modified Eagle medium supplemented with 10% foetal bo-
vine serum (Invitrogen, Life Technologies). For immuno-
fluorescence cells were grown on poly-L-lysine coated
coverslips. Cells were transfected with expression plasmids
or mixture of a plasmid and FUS siRNAs using Lipofecta-
mine2000 (Invitrogen, Life Technologies) according to the
manufacturer’s instructions. For plasmid co-transfections
equal amounts of plasmid DNA were taken into the reac-
tion. For FUS knockdown FUS-specific SiGENOME
SMART pool (M-009497-02, Thermo Scientific) was used.
For nucleolus staining living cells were exposed to 10 μg/
ml of ethidium bromide for 1 hour prior to fixation. To
block transcription, cells were treated with 5 μg/ml actino-
mycin D (Calbiochem, Merck Millipore) for 1 hour. To in-
duce formation of stress granules, cells were subjected to
5 mM sodium arsenite (Sigma) for 1 hour, 2 μM thapsi-
gargin (Sigma) for 4 hours or 50 μM 15-deoxy-delta
12,14-prostaglandin J2 (15d-PGJ2, Cayman Chemical) for
1 hour.
Immunofluorescence on coverslips
Cells were fixed with 4% paraformaldehyde on ice for
15 min, followed by washes with PBS and 5 min perme-
bealization in cold methanol. After three washes with PBS
and blocking in 5% goat serum/PBS/0.1% Triton-X100 for
1 h at room temperature coverslips were incubated with
primary antibodies diluted in blocking solution for 1 h at
room temperature or at 4°C overnight. Alexa Fluor-
conjugated anti-mouse or anti-rabbit immunoglobulins
(Molecular Probes, Life Technologies) were used as sec-
ondary antibodies (1:1000 in PBS/0.1% Triton-X100) and
cell nuclei were visualized with DAPI. For RNA-FISH, a
commercially available NEAT1 and MALAT1 probes(Stellaris® FISH Probes against human NEAT1 5′ segment
and human MALAT1, Biosearch Technologies) was used
according to the protocol provided by the manufacturer.
Fluorescent images were taken using BX61 microscope
(Olympus) and processed using CellF software (Olympus).
For assessing cytoplasmic redistribution of CREST under
stress, fluorescence intensity was measured 24 hours after
transfection in naïve and sodium-arsenite treated cells in
three 2.5 × 2.5 μm squares randomly chosen in the cyto-
plasm of a transfected cell using free-access ImageJ soft-
ware. To estimate the enrichment of full-length CREST
and CR_dNT in SGs, fluorescence intensity was measured
in three 0.5 × 0.5 μm squares in the cytoplasm free from
SGs and in three 0.5 × 0.5 μm squares within SGs of a
transfected cell. Mean intensities per cell were calculated
and used to calculate standard deviation and standard
error of the mean (s.e.m.), as well as ratio SG/cytoplasm.Live cell imaging
Time-lapse images were obtained using Leica TCS SP2
MP confocal microscope, equipped with an on-scope in-
cubator with temperature control. SH-SY5Y cells were
plated on glass-bottomed dishes (Mattek) and transfected
with a plasmid to express CREST-GFP. Before imaging,
regular culture media was replaced with HEPES-buffered
media (10 mM HEPES-KOH, pH7.5). Cells were visual-
ized under Fluotar L 63 × 1.4 oil objective. A sequence of
images was further transformed into a video clip using
Leica Application Suite AF software.Primary mouse hippocampal cultures
All reagents used for preparation of hippocampal cul-
tures were purchased from Invitrogen, Life Technologies
unless stated otherwise. Hippocampi were dissected from
mice at postnatal day 3, digested for 40 minutes in 0.1%
trypsin in HBSS supplemented with 10 mM Hepes and
1 mM pyruvate. After mechanical dissociation in Neurobasal
A medium containing 50 U/ml penicillin/streptomycin,
0.2% β-mercaptoethanol, 500 μM L-Glutamine and 10%
horse serum, hippocampi were centrifuged for 5 minutes
at 1,500 rpm. Pellets were resuspended in fresh medium
and plated on poly-L-lysine coated coverslips. One day
after plating the medium was changed to serum-free
medium containing B27. Mixed neuronal-glial cultures
were transfected on DIV5 using Lipofectamine2000
according to the standard procedure, except Lipofectamin-
DNA complexes which were left for 1 hour and subse-
quently replaced with normal culture medium. Cells were
fixed and stained 48 hours after transfection. Estimation of
dendritic length, number of dendritic trees and Sholl ana-
lysis were performed using Matlab5 software. At least 100
neurons from four independent experiments were analysed
per variant.
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Commercially available primary antibodies against the
following antigens were used: CREST (rabbit polyclonal,
12439-1-AP, Proteintech); FUS (mouse monoclonal against
C-terminus, Santa Cruz, sc-47711; rabbit polyclonal,
ab84078, Abcam); p54nrb (rabbit polyclonal C-terminal,
Sigma); TIAR (mouse monoclonal, BD Biosciences);
G3BP1 (mouse monoclonal, BD Biosciences); Dcp1a
(rabbit polyclonal C-terminal, Sigma); anti-Flag M2 (mouse
monoclonal, Sigma); PSPC1 (rabbit polyclonal C-terminal,
Sigma); GFP (Living Colours® rabbit polyclonal, Clontech,
#632593); SMN (mouse monoclonal, BD Biosciences); cyc-
lin A (rabbit polyclonal, Santa Cruz, sc-751); p80 coilin
(mouse monoclonal, BD Biosciences); PML (chicken poly-
clonal, a kind gift from Prof. Ronald Hay, Dundee); phos-
phorylated tau (mouse monoclonal, clone AT8, Thermo
Scientific); beta-actin (mouse monoclonal, clone AC15,
Sigma); alpha-tubulin (mouse monoclonal, clone DM1A,
Sigma). Primary antibodies were used at 1:1,000 dilution
for all applications.
Protein stability
SH-SY5Y cells were transfected with corresponding con-
structs and allowed to express the protein for 24 hours.
To block translation, cycloheximide (Sigma) was added
to a final concentration of 20 μg/ml; cells were harvested
after 8, 12, 24, 36 and 48 hours of exposure.
Sequential protein extraction
HEK293 cells were transfected with corresponding con-
structs and harvested 24 hours post-transfection. Cells
were disrupted mechanically in high-salt buffer contain-
ing protease inhibitors and centrifuged at 13,000 rpm to
remove cell debris; a small amount was kept as total lys-
ate. Samples were subjected to ultracentrifugation at
48,000 rpm for 20 min and supernatant was recovered
as high-salt soluble fraction (HS). Resulting pellets were
resuspended in high-salt buffer supplemented with 1%
Triton-X100 and centrifuged again under the same con-
ditions. Supernatant was labelled as Triton-X100 soluble
fraction (TX). The same steps were repeated with RIPA
buffer to obtain RIPA-soluble fraction (RIPA). Final pel-
lets were lysed directly in SDS-PAGE loading buffer to
yield SDS-soluble fraction (SDS). Protein amounts in dif-
ferent fractions were normalized against the protein
amount in the high-salt fraction. For total lysate (L) and
high-salt (HS) fraction 10% of the amount relative to
other fractions was loaded.
RT-PCR and qPCR
Total RNA was isolated using RNeasy mini kit (Qiagen)
and possible DNA contamination removed using RNase
free DNase kit (Qiagen). First-strand cDNA synthesis
was carried out on 500 ng of RNA using SuperScript IIIreverse transcriptase (Invitrogen, Life Technologies) and
random hexamers (Promega) according to manufacturer’s
instructions. Quantitative real-time PCR was run in tripli-
cate on an ABI StepOne™ real-time PCR instrument and
data were analyzed using StepOne™ Software v2.0 (Applied
Biosystems, Life Technologies). cDNA amount for each
gene was normalized to that of GAPDH. Primer se-
quences used were as follows: CREST - forward: 5′-
ggttacgcagcaaaccatcc-3′, reverse: 5′-ggatctgctggtactg
cgtg -3′; NEAT1 - forward: 5′-cttcctccctttaacttatccattcac-
3′, reverse: 5′-ctcttcctccaccattaccaacaatac-3′; GAPDH -
forward: 5′-tcgccagccgagcca-3′; reverse: 5′-gagttaaaagcag
ccctggtg-3′.
Immunoprecipitation
Cells were washed with PBS, lysed in ice cold IP buffer
(PBS/1% Triton-X100) on ice with periodic vortexing for
10 min. Unbroken cells and cell debris were pelleted at
13000 rpm for 15 min, input sample was taken at this
point. Cell lysates were incubated with GFP-Trap® agar-
ose beads (ChromoTek) for 2 hours at 4°C. Beads were
washed four times with ice cold high-salt buffer (20 mM
Tris, 300 mM NaCl, 1% Triton-X100) and bound com-
plexes were eluted from beads by boiling for 5 min at
100°C in SDS-PAGE loading buffer. To remove beads,
samples were centrifuged at 13000 × g for 5 min. Sam-
ples were then analyzed by Western blotting. For input
10% of final IP sample was loaded.
Western blotting
For SDS-PAGE loading buffer was used to lyse cells on
dishes, followed by denaturation at 100°C for 5 min.
After SDS-PAGE, proteins were transferred to PVDF
membrane by semi-dry blotting followed by blocking, in-
cubation with primary and HRP-conjugated secondary
(GE Healthcare) antibodies and ECL detection as de-
scribed previously [55]. Equal loading was confirmed by
re-probing membranes with antibodies against beta-actin
or alpha-tubulin.
Semi-Denaturating Detergent Agarose Gel Electrophoresis
(SDD-AGE)
A protocol described previously [56] was used with
modifications indicated below. Briefly, SH-SY5Y cells
were harvested 24 hours post transfection in PBS-1%
Triton-X100, left on ice for 20 min with periodic vortex-
ing and centrifuged at 17,000 × g. To obtain a positive
control for the presence of amyloid aggregates the spinal
cord of a 6-month old transgenic TauP301S mouse was
processed in parallel with cell lysates. Supernatants were
mixed with equal amounts of 2X SDD-AGE loading buf-
fer (1XTAE, 5% glycerol and 1% SDS) and run in 1.5%
agarose containing 0.1% SDS. Proteins from the gel were
transferred to nitrocellulose membrane using capillary
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blotting using anti-CREST and anti-phosphorylated tau
antibodies as described above.
Generation and characterization of transgenic flies
Constructs encoding human wild-type or mutant
CREST, or lacZ in pUAST vector, were injected into
w1118 embryos to produce transgenic flies as described
previously [57,58]. At least three independent transfor-
mant lines were analyzed per construct. gmr-GAL4 and
UAS-lacZ lines were obtained from the Bloomington
Drosophila stock center. For immunoblot analysis, heads
of 5-day-old flies were dissected and lysed in Laemmli
sample buffer for SDS-PAGE containing 2% SDS. For
external surface observation, 5-day-old flies were anes-
thetized with CO2 and observed with zoom stereo mi-
croscopy (Olympus SZ-PT). For histochemical analyses,
heads of 5-day-old adult transgenic flies were dissected,
collected, briefly washed in phosphate buffered saline
(PBS), and fixed with 4% paraformaldehyde containing
0.1% Triton X-100 at room temperature for 2 hours.
After brief wash in PBS, tissues were dehydrated by
graded ethanol, cleared in butanol and embedded in par-
affin. Four-micrometer thick coronal sections were
stained with hematoxylin and eosin (H&E) [58].
Statistics
Statistical analysis was performed with Mann-Whitney
U-test using STATISTICA 6.0 software.Additional files
Additional file 1: Figure S1. Overexpressed CREST aggregates in a
dose-dependent manner in COS7 cells. Flag- or GFP-tagged CREST protein
displays diffuse and fine-granular distribution in the nucleus of
low-expressing COS7 cells and forms dot-like aggregates as it accumulates.
In cells with high levels of the protein, large nuclear aggregates together
with cytoplasmic accumulation/aggregation are observed. Cells were
analysed 24 hours post-transfection. Scale bar, 10 μm.
Additional file 2: Video S1. Time- and concentration-dependent
aggregation of CREST in the nucleus. SH-SY5Y cells were transfected
with the expression plasmid encoding CREST fused to GFP and imaged
8 hours post-transfection. Note the fusion of dot-like CREST aggregates to
each other and aggregate growth with time. QuickTime Player file (.mov).
Additional file 3: Figure S2. ALS-linked CREST mutations do not alter
the protein’s ability for stress granule or paraspeckle recruitment. (A) All
CREST variants are recruited to sodium arsenite induced stress granules.
(B) All CREST mutants sequester endogenous FUS protein into
nuclear aggregates. (C) Mutations in CREST do not affect its
enrichment in paraspeckles in low-expressing SH-SY5Y cells. Scale
bars, A, B - 10 μm, C - 5 μm.
Additional file 4: Figure S3. Polyclonal anti-CREST antibody is
cross-reactive to human FUS protein. (A) Aggregates formed by FUS-GFP
R522G or FUS deletion mutant NT-RRM lacking C-terminal domains
displayed high immunoreactivity with CREST antibody. Aggregates of
GFP-tagged TDP-43 with deleted NLS were not recognised by this
antibody ruling out possible cross-reactivity with GFP tag or non-specific
recognition of aggregated protein species. (B) Full-length FUS and its
deletion mutants are recognized by CREST antibody on Westernblots. Specific bands corresponding to GFP-tagged FUS and its deletion
mutants dRRM (lacking RRM), dR-R (lacking RRM and RGG3) and NT-RRM
(lacking entire C-terminus, amino acids 360-526) are indicated with asterisks.
Open arrow points to endogenous CREST protein and black arrows point to
non-specific bands. Scale bar, 10 μm.
Additional file 5: Figure S4. CREST overexpression in Drosophila
melanogaster retinal neurons results in retinal degeneration. (A) Transgenic
fly lines expressing normal human CREST or its mutants I123M and
Q388stop in retinal photoreceptor neurons with different levels of
protein expression were generated. Protein levels were measured in
the heads of transgenic flies by Western blotting using anti-CREST
antibody and band intensities were quantified (bar chart shows
mean ± s.d., CREST WT line #2 = 1.0). (B,C) Expression of wild-type or
mutant CREST leads to severe retinal degeneration as evidenced by
eye depigmentation (B) and its abnormal histology (C, H&E staining).
The chromosome with transgene insertion (Ch) for each line is indicated.
Abbreviations
15d-PGJ2: 15-deoxy-delta 12, 14-prostaglandin J2; ALS: Amyotrophic lateral
sclerosis; FTLD: Frontotemporal lobar degeneration; MFD: Multifunctional
domain; NEAT1: Nuclear enriched abundant transcript 1; RNP: Ribonucleoprotein;
RRM: RNA recognition motif; SA: Sodium arsenite; SDD-AGE: Semidenaturating
detergent agarose gel electrophoresis; SG: Stress granule.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
TAS, MSK, AQ, TM, KM and HA performed experiments; TAS, MSK, AQ, TH, TI
and VLB designed experiments and analyzed data; TAS, TH and VLB wrote
manuscript. All authors read and approved the final version of the
manuscript.
Acknowledgements
We are grateful to Johnathan Cooper-Knock for critical reading of the manuscript.
This work was supported by Research Grants from Motor Neuron Disease
Association (Buchman/Apr13/6096); Russian Scientific Fund (No. 14-14-01138);
Russian Foundation for Basic Research (No.14-04-00796 and No.14-04-01243).
AQ was supported by Erasmus studentship.
Author details
1School of Biosciences, Cardiff University, Museum Avenue, CF10 3AX Cardiff,
UK. 2Institute of Physiologically Active Compounds Russian Academy of
Sciences, 1 Severniy proezd, Chernogolovka, 142432 Moscow Region, Russian
Federation. 3Department of Neuropathology, The University of Tokyo, Tokyo,
Japan.
Received: 19 December 2014 Accepted: 25 March 2015
References
1. Robberecht W, Philips T. The changing scene of amyotrophic lateral
sclerosis. Nat Rev Neurosci. 2013;14:248–64.
2. Droppelmann CA, Campos-Melo D, Ishtiaq M, Volkening K, Strong MJ. RNA
metabolism in ALS: when normal processes become pathological.
Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:321–36.
3. Ramaswami M, Taylor JP, Parker R. Altered ribostasis: RNA-protein granules
in degenerative disorders. Cell. 2013;154:727–36.
4. Chesi A, Staahl BT, Jovicic A, Couthouis J, Fasolino M, Raphael AR, et al.
Exome sequencing to identify de novo mutations in sporadic ALS trios. Nat
Neurosci. 2013;16:851–5.
5. Teyssou E, Vandenberghe N, Moigneu C, Boillee S, Couratier P, Meininger V,
et al. Genetic analysis of SS18L1 in French amyotrophic lateral sclerosis.
Neurobiol Aging. 2014;35(1213):e1219–1212.
6. Aizawa H, Hu SC, Bobb K, Balakrishnan K, Ince G, Gurevich I, et al. Dendrite
development regulated by CREST, a calcium-regulated transcriptional activator.
Science. 2004;303:197–202.
7. Storlazzi CT, Mertens F, Mandahl N, Gisselsson D, Isaksson M, Gustafson P,
et al. A novel fusion gene, SS18L1/SSX1, in synovial sarcoma. Genes
Chromosomes Cancer. 2003;37:195–200.
Kukharsky et al. Molecular Neurodegeneration  (2015) 10:20 Page 17 of 188. Walton MR, Dragunow I. Is CREB a key to neuronal survival? Trends
Neurosci. 2000;23:48–53.
9. Staahl BT, Tang J, Wu W, Sun A, Gitler AD, Yoo AS, et al. Kinetic analysis of
npBAF to nBAF switching reveals exchange of SS18 with CREST and
integration with neural developmental pathways. J Neurosci.
2013;33:10348–61.
10. Neale BM, Kou Y, Liu L, Ma’ayan A, Samocha KE, Sabo, et al. Patterns and
rates of exonic de novo mutations in autism spectrum disorders. Nature.
2012;485:242–5.
11. O’Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP, et al. Sporadic
autism exomes reveal a highly interconnected protein network of de novo
mutations. Nature. 2012;485:246–50.
12. Pradhan A, Liu Y. A multifunctional domain of the calcium-responsive
transactivator (CREST) that inhibits dendritic growth in cultured neurons.
J Biol Chem. 2005;280:24738–43.
13. Pradhan A, Liu Y. The calcium-responsive transactivator recruits CREB binding
protein to nuclear bodies. Neurosci Lett. 2004;370:191–5.
14. Naganuma T, Nakagawa S, Tanigawa A, Sasaki YF, Goshima N, Hirose T.
Alternative 3′-end processing of long noncoding RNA initiates construction
of nuclear paraspeckles. EMBO J. 2012;31:4020–34.
15. King OD, Gitler AD, Shorter J. The tip of the iceberg: RNA-binding proteins
with prion-like domains in neurodegenerative disease. Brain Res.
2012;1462:61–80.
16. Han TW, Kato M, Xie S, Wu LC, Mirzaei H, Pei J, et al. Cell-free formation of
RNA granules: bound RNAs identify features and components of cellular
assemblies. Cell. 2012;149:768–79.
17. Kato M, Han TW, Xie S, Shi K, Du X, Wu LC, et al. Cell-free formation of RNA
granules: low complexity sequence domains form dynamic fibers within
hydrogels. Cell. 2012;149:753–67.
18. Nishimoto Y, Nakagawa S, Hirose T, Okano HJ, Takao M, Shibata S, et al. The
long non-coding RNA nuclear-enriched abundant transcript 1_2 induces
paraspeckle formation in the motor neuron during the early phase of
amyotrophic lateral sclerosis. Mol Brain. 2013;6:31.
19. Shelkovnikova TA, Robinson HK, Troakes C, Ninkina N, Buchman VL.
Compromised paraspeckle formation as a pathogenic factor in FUSopathies.
Hum Mol Genet. 2014;23:2298–312.
20. Kedersha N, Stoecklin G, Ayodele M, Yacono P, Lykke-Andersen J, Fritzler MJ,
et al. Stress granules and processing bodies are dynamically linked sites of
mRNP remodeling. J Cell Biol. 2005;169:871–84.
21. Kim WJ, Kim JH, Jang SK. Anti-inflammatory lipid mediator 15d-PGJ2 inhibits
translation through inactivation of eIF4A. EMBO J. 2007;26:5020–32.
22. Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, et al.
ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated
nuclear import. EMBO J. 2010;29:2841–57.
23. Shelkovnikova TA, Robinson HK, Southcombe JA, Ninkina N, Buchman VL.
Multistep process of FUS aggregation in the cell cytoplasm involves
RNA-dependent and RNA-independent mechanisms. Hum Mol Genet.
2014;23:5211–26.
24. Bond CS, Fox AH. Paraspeckles: nuclear bodies built on long noncoding
RNA. J Cell Biol. 2009;186:637–44.
25. Tapia O, Bengoechea R, Berciano MT, Lafarga M. Nucleolar targeting
of coilin is regulated by its hypomethylation state. Chromosoma.
2010;119:527–40.
26. Shelkovnikova TA, Robinson HK, Connor-Robson N, Buchman VL. Recruitment
into stress granules prevents irreversible aggregation of FUS protein
mislocalized to the cytoplasm. Cell Cycle. 2013;12:3194–202.
27. Ju S, Tardiff DF, Han H, Divya K, Zhong Q, Maquat LE, et al. A yeast model
of FUS/TLS-dependent cytotoxicity. PLoS Biol. 2011;9:e1001052.
28. Nonaka T, Kametani F, Arai T, Akiyama H, Hasegawa M. Truncation and
pathogenic mutations facilitate the formation of intracellular aggregates of
TDP-43. Hum Mol Genet. 2009;18:3353–64.
29. Austin JA, Wright GS, Watanabe S, Grossmann JG, Antonyuk SV, Yamanaka
K, et al. Disease causing mutants of TDP-43 nucleic acid binding domains
are resistant to aggregation and have increased stability and half-life. Proc
Natl Acad Sci U S A. 2014;111:4309–14.
30. Ling SC, Albuquerque CP, Han JS, Lagier-Tourenne C, Tokunaga S, Zhou H,
et al. ALS-associated mutations in TDP-43 increase its stability and promote
TDP-43 complexes with FUS/TLS. Proc Natl Acad Sci U S A. 2010;107:13318–23.
31. Watanabe S, Kaneko K, Yamanaka K. Accelerated disease onset with
stabilized familial amyotrophic lateral sclerosis (ALS)-linked mutant TDP-43
proteins. J Biol Chem. 2013;288:3641–54.32. Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD. TDP-43 is
intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked
mutations accelerate aggregation and increase toxicity. J Biol Chem.
2009;284:20329–39.
33. Guo W, Chen Y, Zhou X, Kar A, Ray P, Chen X, et al. An ALS-associated
mutation affecting TDP-43 enhances protein aggregation, fibril formation and
neurotoxicity. Nat Struct Mol Biol. 2011;18:822–30.
34. Falsone A, Falsone SF. Legal but lethal: functional protein aggregation at
the verge of toxicity. Front Cell Neurosci. 2015. doi: 10.3389/
fncel.2015.00045.
35. Shelkovnikova TA. Modelling FUSopathies: focus on protein aggregation.
Biochem Soc Trans. 2013;41:1613–7.
36. Li YR, King OD, Shorter J, Gitler AD. Stress granules as crucibles of ALS
pathogenesis. J Cell Biol. 2013;201:361–72.
37. Wolozin B. Regulated protein aggregation: stress granules and
neurodegeneration. Mol Neurodegener. 2012;7:56.
38. Vanderweyde T, Youmans K, Liu-Yesucevitz L, Wolozin B. Role of stress
granules and RNA-binding proteins in neurodegeneration: a mini-review.
Gerontology. 2013;9:524–33.
39. Zhang Z, Carmichael GG. The fate of dsRNA in the nucleus: a p54(nrb)-
containing complex mediates the nuclear retention of promiscuously A-to-I
edited RNAs. Cell. 2001;106:465–75.
40. Hirose T, Virnicchi G, Tanigawa A, Naganuma T, Li R, Kimura H, et al. NEAT1
long noncoding RNA regulates transcription via protein sequestration
within subnuclear bodies. Mol Biol Cell. 2014;25:169–83.
41. Imamura K, Imamachi N, Akizuki G, Kumakura M, Kawaguchi A, Nagata K,
et al. Long noncoding RNA NEAT1-dependent SFPQ relocation from
promoter region to paraspeckle mediates IL8 expression upon immune
stimuli. Mol Cell. 2014;53:393–406.
42. Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, et al.
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause
multisystem proteinopathy and ALS. Nature. 2013;495:467–73.
43. Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, et al.
Characterizing the RNA targets and position-dependent splicing regulation
by TDP-43. Nat Neurosci. 2011;14:452–8.
44. Seyfried NT, Gozal YM, Donovan LE, Herskowitz JH, Dammer EB, Xia Q, et al.
Quantitative analysis of the detergent-insoluble brain proteome in
frontotemporal lobar degeneration using SILAC internal standards.
J Proteome Res. 2012;11:2721–38.
45. Dammer EB, Fallini C, Gozal YM, Duong DM, Rossoll W, Xu P, et al.
Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy
with selective RGG motif methylation and a role for RRM1 ubiquitination. PLoS
One. 2012;7:e38658.
46. Johnson JO, Pioro EP, Boehringer A, Chia R, Feit H, Renton AE, et al.
Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis.
Nat Neurosci. 2014;17:664–6.
47. Couthouis J, Hart MP, Erion R, King OD, Diaz Z, Nakaya T, et al. Evaluating
the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis.
Hum Mol Genet. 2012;21:2899–911.
48. Couthouis J, Hart MP, Shorter J, DeJesus-Hernandez M, Erion R, Oristano R,
et al. A yeast functional screen predicts new candidate ALS disease genes.
Proc Natl Acad Sci U S A. 2011;108:20881–90.
49. Page T, Gitcho MA, Mosaheb S, Carter D, Chakraverty S, Perry RH, et al. FUS
immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions
of neuronal intermediate filament inclusion disease: a frontotemporal lobar
degeneration with FUS proteinopathy. J Mol Neurosci. 2011;45:409–21.
50. Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, Kwiatkowski Jr TJ, et al.
Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate
into stress granules. Hum Mol Genet. 2010;19:4160–75.
51. Pesiridis GS, Lee VM, Trojanowski JQ. Mutations in TDP-43 link glycine-rich
domain functions to amyotrophic lateral sclerosis. Hum Mol Genet.
2009;18:R156–62.
52. Gendron TF, Rademakers R, Petrucelli L. TARDBP mutation analysis in
TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43.
J Alzheimers Dis. 2013;33 Suppl 1:S35–45.
53. van Blitterswijk M, van Es MA, Hennekam EA, Dooijes D, van Rheenen W,
Medic J, et al. Evidence for an oligogenic basis of amyotrophic lateral
sclerosis. Hum Mol Genet. 2012;21:3776–84.
54. Figley MD, Bieri G, Kolaitis RM, Taylor JP, Gitler AD. Profilin 1 Associates with
Stress Granules and ALS-Linked Mutations Alter Stress Granule Dynamics.
J Neurosci. 2014;34:8083–97.
Kukharsky et al. Molecular Neurodegeneration  (2015) 10:20 Page 18 of 1855. Al-Wandi A, Ninkina N, Millership S, Williamson SJ, Jones PA, Buchman VL.
Absence of alpha-synuclein affects dopamine metabolism and synaptic
markers in the striatum of aging mice. Neurobiol Aging. 2010;31:796–804.
56. Halfmann R, Lindquist S. Screening for amyloid aggregation by
Semi-Denaturing Detergent-Agarose Gel Electrophoresis. J Vis Exp.
2008;17:838.
57. Kanda H, Igaki T, Kanuka H, Yagi T, Miura M. Wengen, a member of the
Drosophila tumor necrosis factor receptor superfamilym is required for Eiger
signaling. J Biol Chem. 2002;277:28372–5.
58. Ihara R, Matsukawa K, Nagata Y, Kunugi H, Tsuji S, Chihara T, et al. RNA
binding mediates neurotoxicity in the transgenic Drosophila model of
TDP-43 proteinopathy. Hum Mol Genet. 2013;22:4474–84.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
